The present invention provides Chordin-Like, (CHL) polypeptides and
nucleic acid molecules encoding the same. The invention also provides
selective binding agents, vectors, host cells, and methods for producing
CHL polypeptides. The invention further provides pharmaceutical
compositions and methods for the diagnosis, treatment, amelioration,
and/or prevention of diseases, disorders, and conditions associated with
CHL polypeptides.